108 related articles for article (PubMed ID: 35139586)
1. [Current status of chondrosarcoma in a reference center].
Clara-Altamirano MA; García-Ortega DY; Núñez-González M; Caro-Sánchez CHS; Espejo-Sánchez G; Martínez-Said H; Cuéllar-Hübbe M
Acta Ortop Mex; 2021; 35(4):300-304. PubMed ID: 35139586
[TBL] [Abstract][Full Text] [Related]
2. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
3. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
4. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
5. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
6. Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort.
Thorkildsen J; Taksdal I; Bjerkehagen B; Haugland HK; Børge Johannesen T; Viset T; Norum OJ; Bruland Ø; Zaikova O
Acta Oncol; 2019 Mar; 58(3):273-282. PubMed ID: 30632866
[TBL] [Abstract][Full Text] [Related]
7. The presentation, treatment and outcome of periosteal chondrosarcoma in the Netherlands.
Goedhart LM; Ploegmakers JJ; Kroon HM; Zwartkruis EC; Jutte PC
Bone Joint J; 2014 Jun; 96-B(6):823-8. PubMed ID: 24891585
[TBL] [Abstract][Full Text] [Related]
8. Survival and prognostic factors in conventional G1 chondrosarcoma.
Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
World J Surg Oncol; 2019 Sep; 17(1):155. PubMed ID: 31481076
[TBL] [Abstract][Full Text] [Related]
9. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
10. Outcome of advanced, unresectable conventional central chondrosarcoma.
van Maldegem AM; Gelderblom H; Palmerini E; Dijkstra SD; Gambarotti M; Ruggieri P; Nout RA; van de Sande MA; Ferrari C; Ferrari S; Bovée JV; Picci P
Cancer; 2014 Oct; 120(20):3159-64. PubMed ID: 24995550
[TBL] [Abstract][Full Text] [Related]
11. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and survival in conventional chondrosarcoma: A single institution review.
Chen YC; Wu PK; Chen CM; Tsai SW; Chen CF; Chen WM
J Chin Med Assoc; 2020 Jul; 83(7):669-673. PubMed ID: 32221156
[TBL] [Abstract][Full Text] [Related]
13. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.
Dickey ID; Rose PS; Fuchs B; Wold LE; Okuno SH; Sim FH; Scully SP
J Bone Joint Surg Am; 2004 Nov; 86(11):2412-8. PubMed ID: 15523011
[TBL] [Abstract][Full Text] [Related]
14. Is the Width of a Surgical Margin Associated with the Outcome of Disease in Patients with Peripheral Chondrosarcoma of the Pelvis? A Multicenter Study.
Tsuda Y; Evans S; Stevenson JD; Parry M; Fujiwara T; Laitinen M; Outani H; Jeys L
Clin Orthop Relat Res; 2019 Nov; 477(11):2432-2440. PubMed ID: 31453886
[TBL] [Abstract][Full Text] [Related]
15. Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up.
Andreou D; Ruppin S; Fehlberg S; Pink D; Werner M; Tunn PU
Acta Orthop; 2011 Dec; 82(6):749-55. PubMed ID: 22066552
[TBL] [Abstract][Full Text] [Related]
16. Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.
Laitinen MK; Parry MC; Le Nail LR; Wigley CH; Stevenson JD; Jeys LM
Bone Joint J; 2019 Mar; 101-B(3):266-271. PubMed ID: 30813783
[TBL] [Abstract][Full Text] [Related]
17. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
18. Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients.
Bus MPA; Campanacci DA; Albergo JI; Leithner A; van de Sande MAJ; Gaston CL; Caff G; Mettelsiefen J; Capanna R; Tunn PU; Jeys LM; Dijkstra PDS
J Bone Joint Surg Am; 2018 Feb; 100(4):316-325. PubMed ID: 29462035
[TBL] [Abstract][Full Text] [Related]
19. Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery.
Sheth DS; Yasko AW; Johnson ME; Ayala AG; Murray JA; Romsdahl MM
Cancer; 1996 Aug; 78(4):745-50. PubMed ID: 8756367
[TBL] [Abstract][Full Text] [Related]
20. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF; Goulding KA; Stevens M; Jutte PC
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010778. PubMed ID: 30845364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]